Diff Profiles › MTBLS1490_0002_00000002

Control_16.6_months_vs_Treatment_16.6_months

Control_16.6_months vs Treatment_16.6_months

p-value ≤ 0.05 32 significant 2025-09-26 00:00:00 Study: MTBLS1490
904 Total Features
32 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS1490_0002_00000002
Linked study
MTBLS1490 — Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
Comparison
Control_16.6_months vs Treatment_16.6_months
Group A
Control group with 16.6 months age. Provides baseline for comparison with treated samples at the same age.
Group B
Treated group with 16.6 months age. Represents the effect of treatment at 16.6 months age.
Total features tested
904
Significant features
32
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
MBSKDCPWFSMEFD-WKKMNAASSA-O Peonidin 3-(6''-acetylglucoside) down 1e-06 0.0133
PXSRIASFTWIQOT-QYZSMWKLSA-N [(2R)-3-dodecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate down 1e-06 0.0251
AVPZPEHDIWHRRN-MTFJKWJPSA-N [(2R)-1-icosanoyloxy-3-phosphonooxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate up 1e+06 0.0427
SGEWCQFRYRRZDC-VPRICQMDSA-N Apigenin 8-C-glucoside down 0.08874 0.00155
AUINKJITOILUGW-QBISYZCESA-N — down 0.1448 0.00545
CWTCSQCPFXJPDL-SZQIBGDISA-N — down 0.1172 0.00929
CJHLOIVYCZZNBR-DODNOZFWSA-N — down 0.0941 0.0163
IBUKXRINTKQBRQ-NBURIUCMSA-N — down 0.144 0.0094
VQWOKPHLVOSHNB-JXVUEMGPSA-N — down 0.08062 0.0426
LUTYTNLPIUCKBJ-UHFFFAOYSA-N 1,3,8,9-tetrahydroxy-[1]benzouro[3,2-c]chromen-6-one down 0.1811 0.0252